fluoxetine has been researched along with Koch's Disease in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine also has an additive effect on the effect of isoniazid, and their concomitant use in the delivery system can have significant effects in treating infection of all clinical strains of Mtb." | 1.72 | An effective nano drug delivery and combination therapy for the treatment of Tuberculosis. ( Amiri, V; Delorme, V; Ebrahimzadeh, N; Kasaeian, A; Maleki, M; Masoumi, M; Pourazar, S; Sadeghinia, M; Sheikhpour, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikhpour, M | 1 |
| Delorme, V | 1 |
| Kasaeian, A | 1 |
| Amiri, V | 1 |
| Masoumi, M | 1 |
| Sadeghinia, M | 1 |
| Ebrahimzadeh, N | 1 |
| Maleki, M | 1 |
| Pourazar, S | 1 |
1 other study available for fluoxetine and Koch's Disease
| Article | Year |
|---|---|
An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Fluoxetine; Humans; Isoniazid | 2022 |